Comment on Roxane Labs’ purchase price reduced

Roxane Labs’ purchase price reduced

adcelannotate = {"mobilepaywallcategory" : "MOBILE_PREM-BUSINESS","nativepaywallcategory" : "NATIVE_PREM-BUSINESS"};The price that Jordanian drug company Hikma Pharmaceuticals is paying for Columbus-based Roxane Laboratories has dropped by $535 million. Hikma said in a regulatory filing today that the cash portion of its deal to buy Roxane from its German owners, Boehringer Ingelheim, has been reduced to $647 million.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News